Filing Flows › Relay Therapeutics (RLAY) › Recalls, complaints & regulation
Relay Therapeutics (RLAY): clinical trials
Relay Therapeutics (RLAY) beyond its filings: 4 active clinical trials.
Relay Therapeutics' latest quarter
Relay Therapeutics, Q2 2026: revenue $350K (-48% year over year), net loss $83.7M, operating cash flow −$54.1M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Relay Therapeutics have?
4 active studies on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.